Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A B Atkinson

Showing results (101-110 of 186) with videos related to

Pageof 19
Sort By:
The Ulster Medical Journal|January 1, 1981
Insulinomas in Northern Ireland between 1960 and 1980. A review of 16 casesA B Atkinson, D R Hadden, T L Kennedy, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 1, 1984
Predicting the need for insulin therapy in late onset (40-69 years) diabetes mellitusT J Lyons, L Kennedy, A B Atkinson, et al.
QJM : Monthly Journal of the Association of Physicians|January 5, 2000
Is whole-lung CT scanning still necessary in all cases of ACTH-dependent Cushing's syndrome in the era of petrosal sinus sampling?A Heaney, G Loughrey, D McCance, et al.
Clinical Endocrinology|September 1, 1993
Bilateral adrenalectomy: low mortality and morbidity in Cushing's diseaseD R McCance, C F Russell, T L Kennedy, et al.
Pituitary|December 6, 2005
Poor responses to a test dose of subcutaneous octreotide predict the need for adjuvant therapy to achieve 'safe' growth hormone levelsJ R Lindsay, E M McConnell, S J Hunter, et al.
Journal of Human Hypertension|April 18, 2014
Effect of eplerenone on insulin action in essential hypertension: a randomised, controlled, crossover studyE M McMurray, I R Wallace, C Ennis, et al.
Clinical Endocrinology|August 1, 1986
Studies of hypothalamic pituitary structure and function in patients previously treated with bilateral adrenalectomy alone for Cushing's diseaseR Beacom, A B Atkinson, A L Kennedy, et al.
Clinical Endocrinology|February 1, 1991
A long-term dose-response study of somatostatin analogue (SMS 201-995, octreotide) in resistant acromegalyJ A McKnight, D R McCance, B Sheridan, et al.
Clinical Endocrinology|October 1, 1989
Basal and saline-stimulated levels of plasma atrial natriuretic factor in acromegalyJ A McKnight, D R McCance, D R Hadden, et al.
Archives of Internal Medicine|June 1, 1986
Bromocriptine reduces growth hormone in acromegalyP M Bell, A B Atkinson, D R Hadden, et al.
Pageof 19

Showing results (101-110 of 186) with videos related to

Sort By:
Pageof 19
The Ulster Medical Journal|January 1, 1981
Insulinomas in Northern Ireland between 1960 and 1980. A review of 16 casesA B Atkinson, D R Hadden, T L Kennedy, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 1, 1984
Predicting the need for insulin therapy in late onset (40-69 years) diabetes mellitusT J Lyons, L Kennedy, A B Atkinson, et al.
QJM : Monthly Journal of the Association of Physicians|January 5, 2000
Is whole-lung CT scanning still necessary in all cases of ACTH-dependent Cushing's syndrome in the era of petrosal sinus sampling?A Heaney, G Loughrey, D McCance, et al.
Clinical Endocrinology|September 1, 1993
Bilateral adrenalectomy: low mortality and morbidity in Cushing's diseaseD R McCance, C F Russell, T L Kennedy, et al.
Pituitary|December 6, 2005
Poor responses to a test dose of subcutaneous octreotide predict the need for adjuvant therapy to achieve 'safe' growth hormone levelsJ R Lindsay, E M McConnell, S J Hunter, et al.
Journal of Human Hypertension|April 18, 2014
Effect of eplerenone on insulin action in essential hypertension: a randomised, controlled, crossover studyE M McMurray, I R Wallace, C Ennis, et al.
Clinical Endocrinology|August 1, 1986
Studies of hypothalamic pituitary structure and function in patients previously treated with bilateral adrenalectomy alone for Cushing's diseaseR Beacom, A B Atkinson, A L Kennedy, et al.
Clinical Endocrinology|February 1, 1991
A long-term dose-response study of somatostatin analogue (SMS 201-995, octreotide) in resistant acromegalyJ A McKnight, D R McCance, B Sheridan, et al.
Clinical Endocrinology|October 1, 1989
Basal and saline-stimulated levels of plasma atrial natriuretic factor in acromegalyJ A McKnight, D R McCance, D R Hadden, et al.
Archives of Internal Medicine|June 1, 1986
Bromocriptine reduces growth hormone in acromegalyP M Bell, A B Atkinson, D R Hadden, et al.
Pageof 19